We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IREN icon
3876
Iris Energy
IREN
$16B
$12.4K ﹤0.01%
+2,658
New +$10.2K
FRLA
3877
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$12.4K ﹤0.01%
1,145
+59
+5% +$633
BEAT icon
3878
Heartbeam
BEAT
$32.7M
$12.4K ﹤0.01%
5,127
-37
-0.7% -$85
BXRX
3879
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$12.4K ﹤0.01%
10,558
+9,010
+582% +$8.61K
NYC
3880
American Strategic Investment Co
NYC
$24M
$12.3K ﹤0.01%
1,561
+546
+54% +$4.95K
SYBT icon
3881
Stock Yards Bancorp
SYBT
$2.64B
$12.3K ﹤0.01%
272
-526
-66% -$24.6K
KPLT icon
3882
Katapult Holdings
KPLT
$35.9M
$12.3K ﹤0.01%
548
-70
-11% -$1.06K
GNK icon
3883
Genco Shipping & Trading
GNK
$1.13B
$12.3K ﹤0.01%
878
+91
+12% +$1.31K
HFBL icon
3884
Home Federal Bancorp
HFBL
$73M
$12.3K ﹤0.01%
877
+564
+180% +$8.91K
NYAX
3885
Nayax
NYAX
$2B
$12.3K ﹤0.01%
672
+119
+22% +$2.18K
SMMT icon
3886
Summit Therapeutics
SMMT
$11.2B
$12.3K ﹤0.01%
4,902
-15,972
-77% -$29.1K
ADCT icon
3887
ADC Therapeutics
ADCT
$134M
$12.3K ﹤0.01%
5,721
+5,658
+8,981% +$12.7K
NMTC icon
3888
NeuroOne Medical Technologies
NMTC
$15.9M
$12.3K ﹤0.01%
1,706
+806
+90% +$6.53K
DCOY
3889
Decoy Therapeutics
DCOY
$1.88M
$12.3K ﹤0.01%
+6
New +$13.7K
PSTX
3890
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$12.3K ﹤0.01%
6,963
-9,828
-59% -$25.1K
GRDX
3891
GridAI Technologies Corp
GRDX
$26.8M
$12.2K ﹤0.01%
128
+53
+71% +$7.1K
PIZ icon
3892
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$745M
$12.2K ﹤0.01%
402
+358
+814% +$10.8K
BCML icon
3893
BayCom
BCML
$339M
$12.2K ﹤0.01%
734
-98
-12% -$1.62K
EQRX
3894
DELISTED
EQRx, Inc. Common Stock
EQRX
$12.2K ﹤0.01%
6,577
-5,686
-46% -$10.2K
TAC icon
3895
TransAlta
TAC
$3.99B
$12.2K ﹤0.01%
1,305
-3,191
-71% -$29.9K
OCUL icon
3896
Ocular Therapeutix
OCUL
$2.22B
$12.2K ﹤0.01%
2,360
-166
-7% -$987
FMAO icon
3897
Farmers & Merchants Bancorp
FMAO
$486M
$12.2K ﹤0.01%
540
-573
-51% -$12.6K
TLSA icon
3898
Tiziana Life Sciences
TLSA
$132M
$12.2K ﹤0.01%
17,844
+6,168
+53% +$5.22K
ALNT icon
3899
Allient
ALNT
$1.86B
$12.1K ﹤0.01%
304
-613
-67% -$22.3K
SDOT icon
3900
Sadot Group
SDOT
$11.5M
$12.1K ﹤0.01%
5
+2
+67% +$4.97K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.